• Search
  • Advanced Search
Clin Mol Hepatol > Epub ahead of print
Snapshot
Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats1, Càndid Villanueva1,2
1Hospital Santa Creu and Sant Pau, Autonomous University of Barcelona, Hospital Sant Pau Biomedical Research Institute (IIB Sant Pau), Barcelona, Spain
2Centre for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Barcelona, Spain
Correspondence :  Càndid Villanueva ,
Tel: 34 93 5565920, Fax: 34 93 556 5608, Email: cvillanueva@santpau.cat
Received: February 24, 2024  Revised: March 4, 2024   Accepted: March 4, 2024
KeyWords: Clinically significant portal hypertension; Beta-adrenergic blockers; Liver cirrhosis; Primary prevention
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 473 View
  • 22 Download
ORCID iDs

Càndid Villanueva
https://orcid.org/0000-0002-3674-914X

Related articles

Hemodynamic alterations in cirrhosis and portal hypertension2010 December;16(4)

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension2012 December;18(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 893
TOTAL : 1846232
Close layer